Illlumina Sells Four Genome Analyzers to Singapore Research Center

Xconomy San Diego — 

San Diego-based Illumina (NASDAQ: ILMN), the maker of instruments for genetic analysis, said today it has sold four new Genome Analyzer machines to the Genome Institute of Singapore. Researchers there, who now have six of the machines, plan to use the tools for research of cancer and stem cells. The Singapore center counts several prominent U.S. scientists on its advisory board, including Robert Weinberg of the Whitehead Institute for Biomedical Research and MIT.